ONL Therapeutics raises $4.3M in series A
On May 17, ophthalmic company ONL Therapeutics Inc. (Ann Arbor, Mich.) raised $4.3 million in a series A round, including the conversion of a $1 million bridge loan. Investors included Novartis AG (NYSE:NVS; SIX:NOVN), University...
